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Abstract
Background. The number of women with breast cancer in general practice is rising. To address 
their needs and wishes for a referral, GPs might benefit from more insight into women’s health 
care practices and need for additional support.
Objective. To examine the prevalence of health care use and remaining needs among women with 
breast cancer in the first 15 months after diagnosis.
Methods. In this multicentre, prospective, observational study women with breast cancer completed a 
questionnaire at 6 and 15 months post-diagnosis. Medical data were retrieved through chart reviews. The 
prevalence of types of health care used and remaining needs related to medical, psychosocial, paramedical 
and supplementary service care (such as home care), was examined with descriptive analyses.
Results. Seven hundred forty-six women completed both questionnaires. At both assessments 
patients reported that they had most frequent contact with medical and paramedical providers, 
independent of types of treatment received. Three to fifteen percent of the patients expressed 
a need for more support. Prominent needs included a wish for more frequent contact with a 
physiotherapist, a clinical geneticist and a psychologist. Patients also wanted more help for chores 
around the house, particularly in the early post-treatment phase.
Conclusion. A small but relevant percentage of women with breast cancer report having unmet 
needs. GPs may need to be particularly watchful of their need for more support from specific 
providers. Future research into the necessity of structural needs assessment among cancer patients 
in general practice is warranted.
Key words: Breast neoplasms, cancer survivors, delivery of health care, needs assessment, primary health care, referral and 
consultation.
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Introduction
Breast cancer is the most frequent cancer among women worldwide 
(1). Thanks to the introduction of early detection programs and pro-
gressively successful treatments, the number of breast cancer sur-
vivors keeps increasing. In light of these developments, the role of 
GPs as coordinators of care for cancer survivors and gatekeepers 
to secondary care is growing (2–6). Breast cancer survivors contact 
their GPs with disease-related and treatment-induced effects, such as 
poor physical fitness, motion restriction, lymphedema, fatigue, psy-
chological distress, sleep problems, cognitive problems and meno-
pausal symptoms (7,8). Patients may especially seek their support 
in the period around the completion of primary anti-cancer treat-
ment, as the number of regular contacts with their medical specialists 
and cancer nurse diminishes (e.g. (9–11)). The GPs’ involvement in 
cancer care follow-up has been shown adequate. Health outcomes 
are comparable to hospital-led follow-up in terms of e.g. well-being 
and survival, and possibly at lower costs (12). Patients generally sup-
port a greater role of GPs in their cancer care (13–16). However, they 
report having needs that are not met in general practice (17).
In order to address these needs, GPs would benefit from insight 
into breast cancer patients’ current health care practices and additional 
needs—especially around completion of anti-cancer treatment when 
the needs are highest. While a number of breast cancer-specific studies 
have examined the health care practices of early-stage breast cancer 
survivors (18–24), more research is warranted. First, these studies 
primarily investigated global use of care services—for example, by 
assessing the total number of visits to any type of medical specialist. 
Thus, they generally provide limited insight into women’s use of spe-
cific services (see (18, 20) for exceptions). Second, none of these studies 
additionally examined women’s self-reported remaining needs of spe-
cific services, which would be most relevant given the GP’s role as gate-
keeper to secondary care. A more detailed approach can provide the 
insight needed to deliver tailored care. Therefore, the current nation-
wide study was undertaken to generate a comprehensive overview of 
the types of care used by women with breast cancer, and of their needs 
for additional services in the first 15 months after diagnosis. Within this 
time frame most patients will complete primary anti-cancer treatment, 
and thus especially need the support of their GP.
Methods
Design
This study had a multicentre, prospective, observational design. 
Women were recruited from six academic hospitals, two community 
hospitals and one comprehensive cancer centre in the Netherlands. 
Participants completed a self-report questionnaire at 6  months 
(time window 5 to 7 months) and 15 months (time window 14 to 
16  months) post-diagnosis. Medical data were collected through 
chart review. Following Dutch guidelines and regulations, the study 
was exempted from formal ethical review by the institutional review 
boards of the participating centres, based on its purely observational 
nature. Formal agreement to participation involved providing written 
informed consent.
Participants and recruitment
Women with primary breast cancer diagnosed up to 6 months earlier 
were eligible for the study, irrespective of type of treatment. Patients 
not literate in Dutch, younger than 18 years, and/or with a prognosis 
of 3 months or less were excluded. Participating centres could ex-
clude patients who were participating in a concurrent study.
Eligible women with breast cancer were informed about the study 
by their oncologist or cancer nurse, and subsequently invited to partici-
pate. The investigator then approached interested patients. Participants 
could choose between a paper questionnaire, sent by regular mail, and 
a web-based, e-mailed questionnaire. Formal agreement to participa-
tion involved providing written informed consent. Patients received 
telephone or e-mail reminders after 2 and 4 weeks, if necessary.
Measures
Health care use and remaining needs were measured by self-report 
at 6 and 15  months post-diagnosis. Respondents were asked to 
indicate how often in the past 3 months they had visited a health 
care provider or, respectively, made use of a supplementary breast 
cancer service for breast cancer treatment or related problems (an-
swer categories: 0/1/2/3/4/5/>5 times). The same question format 
was previously used to assess the care practices of other patient 
groups (25,26); for this study we assessed health care use related 
to a breast cancer diagnosis. Twenty-three types of health care use 
were assessed and combined to form the categories medical, para-
medical, psychosocial and supplementary service care. Furthermore, 
we divided medical care into two subgroups. The main providers 
during primary treatment, i.e. surgeons, radiation oncologists, in-
ternists and breast cancer nurses, will be referred to as ‘main med-
ical care providers’. The number of contacts with these providers is 
usually protocol-based. Other medical providers are categorized as 
‘secondary medical care providers’. The health care category ‘sup-
plementary services’ included the following services: paid child care, 
having a nurse at home/home care, domestic help, participation in a 
support group, and/or a group rehabilitation program.
To assess women’s remaining health care needs, respondents 
were asked to indicate the extent to which they found the number 
of contacts with each of the providers and services sufficient (answer 
categories: needed fewer contacts, number of contacts was sufficient, 
needed more contacts).
Sociodemographic and clinical characteristics
Age at diagnosis, nationality, educational level, living situation, em-
ployment status and type of insurance were assessed by self-report at 
the 6 month post-diagnosis assessment.
Type of breast cancer, cancer stage via pTNM-classification, 
types of treatment received, and presence of recurrence (yes/no), 
were retrieved from patients’ medical records. Previous use of 
Key Messages
• Most women with breast cancer find the amount of care received sufficient.
• Up to 15% report having unmet needs at 6 and 15 months post-diagnosis.
• Women want more contact with a physio- or lymphedema therapist.
• Also, women want more support from a clinical geneticist or psychologist.
• As gatekeepers to secondary care, GPs need to be watchful of such needs.
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psychosocial services (yes/no) and the number of comorbid condi-
tions were assessed with the same self-report questionnaire 6 months 
post-diagnosis.
Data analyses
Prior to the main analyses, missing data patterns were examined 
with Little’s missing completely at random test with a chi-square 
statistic (P  <  0.05), and with descriptive analyses, i.e. separate-
variance t-tests, cross tabulations and a tabulated pattern table. The 
results indicated that the data could be assumed to be missing at 
random, thus that the probability that a value was missing depended 
only on the examined variables. The percentage of missing values 
for all the variables ranged from 0.0% to 4.7% for the health care 
use variables, to 20.1% for the health care needs variables. The data 
were subsequently multiply imputed by fully conditional specifica-
tion with a maximum of five iterations (27,28).
The prevalence of health care use and remaining needs was exam-
ined with descriptive analyses. For the analyses of patients’ remaining 
needs, we recoded the answer categories of the need questions into 
having ‘no need’ versus ‘having a need for additional contact’. The 
results, for both care use and remaining needs, are presented for pa-
tients who received only radiotherapy, and for those who received 
radiotherapy as well as adjuvant chemo- and/or hormonal therapy, 
because we expected that the latter group would use more care 
services, and possibly would have other remaining treatment-related 
needs than patients who received only radiotherapy.
We decided post-hoc not to report on the care use and remaining 
needs of patients who only received adjuvant systemic therapy 
(n = 32), and of those who did not receive either radio- or adjuvant 
systemic therapy (n = 46), given the small number of women in these 
categories.
The analyses were conducted with SPSS 22.0 for Windows.
Figure 1. Flowchart for study eligibility: 1353 women with primary breast cancer assessed.
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Results
Sample
In total, 1353 women with breast cancer were assessed for study eli-
gibility, and 1263 were found eligible. One thousand twelve women 
agreed to participate (80.1%). The 746 women who completed both 
the first and second study questionnaire were included in the current 
analyses (73.7% of the participants; Fig. 1).
The majority of participants had stage 1 or 2 invasive breast 
cancer at diagnosis, and most women were treated with lumpectomy 
and radiotherapy. Over 60% had one or more comorbid conditions 
(Table 1). Participants did not differ in age (groups based on median 
split) and cancer stage from the non-respondents, i.e. women who 
were approached by the researcher but who could not be reached, 
declined to participate, or who did not return both questionnaires 
(chi-square, P > 0.10). We did not collect characteristics of eli-
gible patients who did not want to be approached about the study 
(n = 74).
Health care use and remaining needs 6 months 
post-diagnosis
Patients most frequently visited their main medical care providers, 
i.e. their surgeon, radiation oncologist, internist and breast cancer 
nurse (33% or more of the patients). Additionally, they had fre-
quent contact with their GP (48% of the radiotherapy patients and 
67% of the radio- and adjuvant systemic therapy patients). The 
two other most frequently contacted care providers in this period, 
were the occupational physician (28% for patients who received 
radiotherapy and 41% for those who received radio- and adjuvant 
systemic therapy), and the physiotherapist (17% and 31%, respect-
ively). Overall, the most frequently used services between 3 and 
6  months post-diagnosis were the same for women who received 
radiotherapy, and for those who received radio- and adjuvant sys-
temic therapy. However, the frequency of use was, generally, higher 
in the latter group.
The majority of patients found the amount of care received 
sufficient. However, 4–15% of the patients expressed a need for 
more contact with a specific provider or service. Patients who had 
received radiotherapy most often reported wanting more contact 
with a clinical geneticist (15.1%), a physiotherapist (14.3%), a 
sexologist (14.1%), a lymphedema therapist (14.1%) or a psych-
ologist (13.8%). Patients who had received radio- and adjuvant 
systemic therapy most often reported wanting more contact 
with a domestic helper (14.8%), a GP (14.1%), a psychologist 
(11.4%), a support group (11.4%) or a clinical geneticist (11.1%) 
(Table 2).
Health care use and remaining needs 15 months 
post-diagnosis
The patients continued to visit their main medical care providers 
relatively frequently between 12 and 15 months post-diagnosis, al-
though the number of contacts was somewhat lower than 9 months 
earlier. More specifically, over half of all patients visited their 
breast cancer nurse (53.0% for the patients who had radiotherapy 
and 58.1% for the patients who had radio- and adjuvant systemic 
therapy) and surgeon (50.0% and 53.0%, respectively) in the latter 
3-month period. The two other most frequently contacted providers 
were the GP (24.1% for patients who had received radiotherapy and 
43% for patients who had received radio- and adjuvant systemic 
therapy), and the physiotherapist (25.1% and 35.6%, respectively).
Again, a minority, 3–13% of the patients, reported wanting 
more contact with a specific provider or service between 12 and 
15 months post-diagnosis. Patients who had received radiotherapy 
Table 1.  Sample characteristics of 746 women with primary breast 
cancer, data collection in 2011–2014
Characteristics Total samplea
Sociodemographic factors  
Age at diagnosis (median, range) 58 (24–83)
Nationality (n, %)  
 Dutch only 716 (96.0)
 Dutch and other or other only 30 (4.0)
Educational level (n, %)a  
 Low 345 (46.2)
 Intermediate 185 (24.8)
 High 215 (29.0)
Living situation (n, %)  
 With partner 383 (51.3)
 With partner and child(ren) 192 (25.7)
 With child(ren) 34 (4.6)
 Alone 128 (17.2)
 Other 9 (1.2)
Employment status (n, %)  
 Paid work 272 (39.7)
 Homemaker 136 (19.8)
 Retired 191 (27.8)
 No work or unpaid 34 (5.0)
 (Partly) work-disabled due to breast cancer 53 (7.7)
Type of breast cancer (n, %)  
 Ductal carcinoma in situ (DCIS) 104 (13.9)
 Invasive and DCIS 57 (7.6)
 Invasive 585 (78.4)
Cancer stage at diagnosis (n, %)  
 TIS 104 (13.9)
 Invasive early stage (T1/T2) 622 (83.4)
 Invasive late stage (T3/T4) 20 (2.7)
Type of surgery (n, %)  
 Lumpectomy 630 (84.5)
 Mastectomy 105 (14.1)
 Lumpectomy and mastectomy 9 (1.2)
 No lumpectomy or mastectomy 2 (0.3)
Radio-, chemo- and/or hormonal therapy (n, %)  
 Radiotherapy only 370 (49.6)
 Radiotherapy with chemo- and/or hormonal therapy 298 (39.9)
 Chemotherapy and/or hormonal therapy 32 (4.3)
 No radio-, chemo-, or hormonal therapy 46 (6.2)
Other types of treatment (n, %; yes/no)  
 Sentinel lymph node dissection 642 (86.1)
 Axillary lymph node dissection 97 (13)
 Immunotherapy 32 (4.3)
Recurrence (n, %)  
 No 731 (98.0)
 Yes 15 (2.0)
Previous use of psychosocial services (n, %)  
 No 577 (77.3)
 Yes 169 (22.7)
Comorbidity (n, %)  
 0 comorbid disorders 280 (37.5)
 1 comorbid disorder 232 (31.1)
 2 or more comorbid disorders 234 (31.4)
aEducational level was categorized as low (no education, elementary school, 
low level vocational education, or intermediate level high school), intermediate 
(intermediate level vocational education, or high level high school) and high 
(high level vocational education, or college or university).
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most often indicated a need for more contact with a physiotherapist 
(15.7%), domestic helper (14.6%), lymphedema therapist (13.2%), 
clinical geneticist (12.2%) or an occupational therapist (10.8%). 
Patients who had received radio- and adjuvant systemic therapy 
most often reported wanting more contact with a physiotherapist 
(13.1%), a psychologist (11.4), a breast cancer nurse (11.1%), a 
domestic help provider (11.1%) or a group rehabilitation program 
(11.1%) (Table 2).
Discussion
In the period about 6 months and 15 months post-diagnosis women 
with breast cancer reported to most often visit medical and para-
medical care services. The most frequently used services were similar 
for women who received radiotherapy, and those who received 
radio- and adjuvant systemic therapy. Up to 15%, reported having 
unmet needs, at both assessment points. GPs may need to be particu-
larly watchful of women’s need for more support from a physiother-
apist, a lymphedema therapist, a clinical geneticist or a psychologist.
With regard to health care use, we observed a noticeable increase 
in the proportion of women who used physio- or lymphedema therapy 
between diagnosis and 15 months later. This finding is most likely re-
lated to the experience of side-effects as lack of muscle strength and a 
rise in the incidence of lymphedema, especially during the first 2 years 
after diagnosis or surgery of breast cancer. Prior research indicated 
that the impact of these problems on health care use may remain, up 
to more than 10 years after a breast cancer diagnosis (29,30).
Noteworthy with regard to women’s remaining needs is that a 
relatively high proportion of women would like more support from 
a clinical geneticist. Although some women may indeed require con-
tact with a clinical geneticist based on family history or other po-
tential risk factors (e.g. young age at diagnosis), for many women 
advice from their GP about genetic risk may be sufficient (31). It is 
important to note that a substantial percentage of surgeons, medical 
oncologists, radiation oncologists and radiologists (11–56%, de-
pending on the criteria used) do not always refer women who meet 
the criteria for BRCA-testing for genetic counselling and testing (32). 
Our results imply that heightened awareness among GPs regarding 
the potential need for referral to genetic services early post-treatment 
is warranted.
A finding with even larger clinical implications relates to the 
relatively high percentage of women who reported an unmet need 
Table 2.  Health care use and remaining needs 6 and 15 months post-diagnosis of women with primary breast cancer, data collection in 
2011–2014a
Time period 6 months post-diagnosis 15 months post-diagnosis
Type of treatment Radiotherapy (n = 370) Radio- and adjuvant  
therapy (n = 298)
Radiotherapy (n = 370) Radio- and adjuvant 
therapy (n = 298)
















Main medical care providers
 Surgeon 210 (56.8) 36 (9.7) 181 (60.7) 32 (10.7) 185 (50.0) 24 (6.5) 158 (53.0) 17 (5.7)
 Radiation oncologist 302 (81.6) 23 (6.2) 252 (84.6) 12 (4.0) 126 (34.1) 25 (6.8) 99 (33.2) 16 (5.4)
 Internist/internist-medical oncologist 125 (33.8) 29 (7.8) 254 (85.2) 24 (8.1) 84 (22.7) 20 (5.4) 152 (51.0) 32 (10.7)
  Breast cancer nurse/nurse specialist  
oncology/nurse practitioner
289 (78.1) 45 (12.2) 265 (88.9) 14 (4.7) 196 (53.0) 24 (6.5) 173 (58.1) 33 (11.1)
Secondary medical care providers
 GP 179 (48.4) 47 (12.7) 200 (67.1) 42 (14.1) 89 (24.1) 39 (10.5) 106 (35.6) 20 (6.7)
 Plastic surgeon 30 (8.1) 43 (11.6) 19 (6.4) 22 (7.4) 22 (5.9) 33 (8.9) 19 (6.4) 22 (7.4)
 Sexologist 0 (0.0) 52 (14.1) 0 (0.0) 21 (7.0) 0 (0.0) 33 (8.9) 7 (2.3) 24 (8.1)
 Gynecologist 16 (4.3) 37 (10.0) 34 (11.4) 22 (7.4) 25 (6.8) 33 (8.9) 30 (10.1) 19 (6.4)
 Clinical geneticist 28 (7.6) 56 (15.1) 41 (13.8) 33 (11.1) 24 (6.5) 45 (12.2) 37 (12.4) 28 (9.4)
 Occupational physician 104 (28.1) 36 (9.7) 121 (40.6) 23 (7.7) 59 (15.9) 40 (10.8) 88 (29.5) 22 (7.4)
 Lymphedema therapist 36 (9.7) 52 (14.1) 51 (17.1) 28 (9.4) 68 (18.4) 49 (13.2) 84 (28.2) 29 (9.7)
Psychosocial care providers
 Psychologist or psychotherapist 34 (9.2) 51 (13.8) 28 (9.4) 34 (11.4) 32 (8.6) 58 (15.7) 45 (15.1) 34 (11.4)
 Social worker 18 (4.9) 38 (10.3) 25 (8.4) 24 (8.1) 17 (4.6) 38 (10.3) 20 (6.7) 21 (7.0)
 Psychiatrist 11 (3.0) 38 (10.3) 11 (3.7) 15 (5.0) 11 (3.0) 36 (9.7) 9 (3.0) 21 (7.0)
 Spiritual care provider 25 (6.8) 39 (10.5) 17 (5.7) 20 (6.7) 27 (7.3) 39 (10.5) 13 (4.4) 25 (8.4)
Paramedical care providers
 Physiotherapist 65 (17.6) 53 (14.3) 93 (31.2) 29 (9.7) 93 (25.1) 40 (10.8) 130 (43.6) 39 (13.1)
 Dietician 22 (5.9) 35 (9.5) 14 (4.7) 31 (10.4) 17 (4.6) 42 (11.4) 16 (5.4) 30 (10.1)
 Ergotherapist 7 (1.9) 43 (11.6) 6 (2.0) 19 (6.4) 14 (3.8) 38 (10.3) 12 (4.0) 20 (6.7)
Supplementary breast cancer services
 Paid child care 11 (3.0) 41 (11.1) 12 (4.0) 24 (8.1) 14 (3.8) 37 (10.0) 9 (3.0) 26 (8.7)
 Nurse at home/home care 25 (6.8) 30 (8.1) 27 (9.1) 25 (8.4) 15 (4.1) 46 (12.4) 14 (4.7) 20 (6.7)
 Domestic help 42 (11.4) 44 (11.9) 53 (17.8) 44 (14.8) 24 (6.5) 54 (14.6) 38 (12.8) 33 (11.1)
 Support group 16 (4.3) 48 (13.0) 16 (5.4) 34 (11.4) 17 (4.6) 48 (13.0) 19 (6.4) 29 (9.7)
 Group rehabilitation program 19 (5.1) 49 (13.2) 21 (7.0) 32 (10.7) 23 (6.2) 41 (11.1) 54 (18.1) 33 (11.1)
aCare use and remaining needs within the past 3 months. In bold: care use and need percentages ≥ 10%.
bUse: the number/percentage of patients who used a specific service at least once in the past 3 months.
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for support from a sexologist. This result is congruent with a pre-
vious finding that few women with breast cancer seek help for sexual 
issues despite a considerable need to discuss sexual concerns (33). It 
has been well established that physicians, cancer nurses, as well as 
patients, may still be hesitant to initiate a conversation about sexual 
health. As a consequence, related problems remain undetected (34).
Likewise, the finding that women want more support from psy-
chosocial caregivers corresponds with findings of other studies that 
problems such as anxiety, fears about the cancer spreading, and lack 
of control are not adequately discussed during patient-physician 
consultations (35). This is a well-known concern, not only in on-
cology settings (36), but also in general practice (17). We did not find 
many reports about structural use of a screening instrument such as 
the Distress Thermometer and accompanying Problem List in gen-
eral practice. Yet, as in oncology settings such use may be necessary 
to further facilitate accurate assessment of cancer patients’ distress 
level, distress-related problems and wish for referral to professional 
care. A qualitative study showed that GPs who were willing to use 
such a questionnaire, found it clinically useful (37). Given the GPs’ 
growing role as coordinators of care for cancer survivors, and gate-
keepers to secondary care, the need to implement cancer-specific 
psychosocial assessments in general practice deserves further investi-
gation (see also (37,38)).
An additional benefit of using an instrument such as the Distress 
Thermometer is that patients’ experience of practical or financial 
problems is also assessed. To ensure that women’s needs are actually 
addressed, GPs should also assess possible barriers to care and dis-
cuss feasible solutions, if needed.
Strengths of the study include its large sample size, its multicentre, 
nationwide prospective design and its focus on the early post-
treatment phase—which up to now has scarcely  been examined. 
The role of GPs as coordinators of cancer care is likely to expand 
from this phase onwards. In contrast to most previous studies, this 
study did not examine which problems women experience. Instead, 
we examined which range of providers they would like to visit. The 
results offer practical insight into possible referral wishes of breast 
cancer patients. Clearly, GPs will have to decide whether these 
wishes are justified from a clinical point of view. A possible limi-
tation is that many participants were recruited at radiotherapy de-
partments. Consequently, patients who did not receive radiotherapy 
were underrepresented in our sample. A  previous study based on 
data from a Dutch population-based, regional cancer registry indi-
cated that 17% of the women with breast cancer received systemic 
therapy without radiotherapy (39). Furthermore, we were unable to 
gather information about patients who declined to be approached, 
and thus cannot ensure our sample’s representativeness in that re-
gard. Finally, the percentage of missing values for some health care 
need variables, prior to imputation, was relatively high (up to 20%). 
One reason for these missing data is that some respondents skipped 
the need questions for the services they had not used. Nevertheless, 
our analyses indicate that these data can still be assumed to be 
missing at random.
In light of the increasing number of women with breast cancer, 
we recommend that future studies also employ qualitative methods 
to investigate patients’ most prominent care needs in the post-
treatment period. Qualitative analyses can provide insight into why 
patients would like specific referrals. It may turn out that some pa-
tients want to make costly visits to specialists for problems that 
could also be addressed as effectively, if not better, by, for example, a 
GP, a breast cancer nurse, or a support group. Additionally, there is a 
need for studies that examine health care use respectively care needs 
and predictors thereof over longer periods of time, to enable timely 
identification of the women in the post-treatment and survival phase 
with the most prominent care use and needs (40).
Acknowledgements
We thank all the women who were willing to participate. We thank all care 
providers and researchers who contributed to this study. We especially thank 
Corry Marijnen (LUMC); Joyce Roijen, Annemie Courtens (MUMC); Sjane 
Olsthoorn (Erasmus MC – Cancer Institute); Mary-Ann Thoms, Irma van 
Gelderen (Reinier de Graaf Hospital); Jan Anne Roukema (St. Elisabeth 
Hospital); Anna Reyners, Wieke Huisman-de Haan, Greetje Akerboom, 
Hennie Wilpstra-Dijkema, John Maduro (UMCG); Ingrid de Vries, Petra 
Duijveman, Marieke van de Grootevheen, Arjan van Hoorn, Sanne van 
Munster (UMCU); Pietje Muller, Susanne Kuiper (NKI-AVL); Kate Sitnikova, 
Jane van der Vloodt, Maha van der Plas, Linde Mollers, Anke Edink, Esmee 
van Vliet, Jeroen Gomes, Elvira Don, Rob van Os (AMC).
Declarations
Funding: supported by Pink Ribbon Foundation Netherlands the Netherlands 
(grant number 2009.PS.C50). The funding source had no role in the design, 
conduct, or reporting of this study, or in the decision to submit the manuscript 
for publication.
Ethical approval: All procedures performed were in accordance with the eth-
ical standards of the institutional and/or national research committee and with 
the 1964 Helsinki declaration and its later amendments or comparable ethical 
standards.
Conflict of interest: none.
References
 1. Ferlay J, Ervik M, Lam F et al. Cancer today (powered by GLOBOCAN 
2018): IARC CancerBase No. 15. https://gco.iarc.fr/today/data/factsheets/
cancers/20-Breast-fact-sheet.pdf (accessed on 8 February 2019).
 2. Campbell  NC, MacLeod  U, Weller  D. Primary care oncology: essential 
if high quality cancer care is to be achieved for all. Fam Pract 2002; 19: 
577–8.
 3. Grunfeld E. Cancer survivorship: a challenge for primary care physicians. 
Br J Gen Pract 2005; 55: 741–2.
 4. McAvoy BR. General practitioners and cancer control. Med J Aust 2007; 
187: 115–7.
 5. Rubin G, Berendsen A, Crawford SM et al. The expanding role of primary 
care in cancer control. Lancet Oncol 2015; 16: 1231–72.
 6. Pascoe SW, Neal RD, Allgar VL, Selby PJ, Wright EP. Psychosocial care for 
cancer patients in primary care? Recognition of opportunities for cancer 
care. Fam Pract 2004; 21: 437–42.
 7. Jefford M, Mann GB, Nolte L et al. Follow-up of women with early stage 
breast cancer. Curr Breast Cancer Rep 2014; 6: 183–92.
 8. Kenyon M, Mayer DK, Owens AK. Late and long-term effects of breast 
cancer treatment and surveillance management for the general practi-
tioner. J Obstet Gynecol Neonatal Nurs 2014; 43: 382–98.
 9. Stanton  AL, Ganz  PA, Rowland  JH, Meyerowitz  BE, Krupnick  JL, 
Sears SR. Promoting adjustment after treatment for cancer. Cancer 2005; 
104(11 Suppl): 2608–13.
 10. Allen JD, Savadatti S, Levy AG. The transition from breast cancer ‘patient’ 
to ‘survivor’. Psychooncology 2009; 18: 71–8.
 11. Laporte C, Vaure J, Bottet A et al. French women’s representations and 
experiences of the post-treatment management of breast cancer and their 
perception of the general practitioner’s role in follow-up care: a qualitative 
study. Health Expect 2017; 20: 788–96.
 12. Lewis RA, Neal RD, Williams NH et al. Follow-up of cancer in primary 
care versus secondary care: systematic review. Br J Gen Pract 2009; 59: 
e234–47.
 13. Meiklejohn JA, Mimery A, Martin JH et al. The role of the GP in follow-up 
cancer care: a systematic literature review. J Cancer Surviv 2016; 10: 990–
1011.









roningen user on 27 February 2020
 14. Nugteren IC, Duineveld LAM, Wieldraaijer T et al. Need for general prac-
titioner involvement and eHealth in colon cancer survivorship care: pa-
tients’ perspectives. Fam Pract 2017; 34: 473–8.
 15. Schütze H, Chin M, Weller D, Harris MF. Patient, general practitioner and 
oncologist views regarding long-term cancer shared care. Fam Pract 2018; 
35: 323–9.
 16. Brandenbarg  D, Roorda  C, Stadlander  M, de  Bock  GH, Berger  MY, 
Berendsen AJ. Patients’ views on general practitioners’ role during treat-
ment and follow-up of colorectal cancer: a qualitative study. Fam Pract 
2017; 34: 234–8.
 17. Hoekstra RA, Heins MJ, Korevaar JC. Health care needs of cancer sur-
vivors in general practice: a systematic review. BMC Fam Pract 2014; 15: 
94.
 18. Edgar L, Remmer J, Rosberger Z, Fournier MA. Resource use in women 
completing treatment for breast cancer. Psychooncology 2000; 9: 428–
38.
 19. Mandelblatt JS, Lawrence WF, Cullen J et al. Patterns of care in early-stage 
breast cancer survivors in the first year after cessation of active treatment. 
J Clin Oncol 2006; 24: 77–84.
 20. Snyder CF, Frick KD, Peairs KS et al. Comparing care for breast cancer sur-
vivors to non-cancer controls: a five-year longitudinal study. J Gen Intern 
Med 2009; 24: 469–74.
 21. Lu  W, Jansen  L, Schaapveld  M, Baas  PC, Wiggers  T, De  Bock  GH. 
Underuse of long-term routine hospital follow-up care in patients with a 
history of breast cancer? BMC Cancer 2011; 11: 279.
 22. Goldstein D, Bennett BK, Webber K et al. Cancer-related fatigue in women 
with breast cancer: outcomes of a 5-year prospective cohort study. J Clin 
Oncol 2012; 30: 1805–12.
 23. Keyzer-Dekker  CM, Van  Esch  L, Schreurs  WH et  al. Health care util-
ization one year following the diagnosis benign breast disease or breast 
cancer. Breast 2012; 21: 746–50.
 24. Roorda C, Berendsen AJ, Groenhof F, van der Meer K, de Bock GH. In-
creased primary healthcare utilisation among women with a history of 
breast cancer. Support Care Cancer 2013; 21: 941–9.
 25. Hartman EE, Sprangers MA, Visser MR et al. Anorectal malformations: 
does healthcare meet the needs? J Pediatr Gastroenterol Nutr 2005; 41: 
210–5.
 26. Schoormans D, Sprangers MA, Pieper PG et al. The perspective of patients 
with congenital heart disease: does health care meet their needs? Congenit 
Heart Dis 2011; 6: 219–27.
 27. van  Buuren  S. Multiple imputation of discrete and continuous data by 
fully conditional specification. Stat Methods Med Res 2007; 16: 219–42.
 28. Azur MJ, Stuart EA, Frangakis C, Leaf PJ. Multiple imputation by chained 
equations: what is it and how does it work? Int J Methods Psychiatr Res 
2011; 20: 40–9.
 29. DiSipio  T, Rye  S, Newman  B, Hayes  S. Incidence of unilateral arm 
lymphoedema after breast cancer: a systematic review and meta-analysis. 
Lancet Oncol 2013; 14: 500–15.
 30. Harrington S, Padua D, Battaglini C et al. Comparison of shoulder flexi-
bility, strength, and function between breast cancer survivors and healthy 
participants. J Cancer Surviv 2011; 5: 167–74.
 31. Watson E, Austoker  J, Lucassen A. A study of GP referrals to a family 
cancer clinic for breast/ovarian cancer. Fam Pract 2001; 18: 131–4.
 32. Van Riel E, Wárlám-Rodenhuis CC, Verhoef S, Rutgers EJ, Ausems MG. 
BRCA testing of breast cancer patients: medical specialists’ referral pat-
terns, knowledge and attitudes to genetic testing. Eur J Cancer Care (Engl) 
2010; 19: 369–76.
 33. Hill EK, Sandbo S, Abramsohn E et al. Assessing gynecologic and breast 
cancer survivors’ sexual health care needs. Cancer 2011; 117: 2643–51.
 34. Fobair P, Spiegel D. Concerns about sexuality after breast cancer. Cancer J 
2009; 15: 19–26.
 35. Fiszer C, Dolbeault S, Sultan S, Brédart A. Prevalence, intensity, and pre-
dictors of the supportive care needs of women diagnosed with breast 
cancer: a systematic review. Psychooncology 2014; 23: 361–74.
 36. National Comprehensive Cancer Network. Distress management: Clinical 
practice guidelines. J Natl Compr Canc Netw 2003; 1: 344–74.
 37. Thayssen  S, Hansen  DG, Søndergaard  J, Høybye  MT, Christensen  PM, 
Hansen HP. Completing a questionnaire at home prior to needs assess-
ment in general practice: a qualitative study of cancer patients’ experience. 
Patient 2016; 9: 223–30.
 38. Carolan CM, Campbell K. General practitioners’ ‘lived experience’ of as-
sessing psychological distress in cancer patients: an exploratory qualitative 
study. Eur J Cancer Care (Engl) 2016; 25: 391–401.
 39. Sukel MP, van de Poll-Franse LV, Nieuwenhuijzen GA et al. Substantial 
increase in the use of adjuvant systemic treatment for early stage breast 
cancer reflects changes in guidelines in the period 1990-2006 in the 
southeastern Netherlands. Eur J Cancer 2008; 44: 1846–54.
 40. Lo-Fo-Wong DNN, de Haes JCJM, Aaronson NK et al. Predicting health 
care use and unmet needs for support among women with breast cancer in 
the post-treatment phase. submitted.









roningen user on 27 February 2020
